Patents by Inventor Monique Berwaer

Monique Berwaer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
    Patent number: 10729653
    Abstract: The present invention relates to an immediate release formulation of pharmaceutical compounds.
    Type: Grant
    Filed: January 27, 2010
    Date of Patent: August 4, 2020
    Assignee: UCB BIOPHARMA SRL
    Inventors: Serge Cuypers, Monique Berwaer, Domenico Fanara, Valery Barillaro
  • Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivative
    Publication number: 20200085754
    Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: July 12, 2019
    Publication date: March 19, 2020
    Inventors: Domenico Fanara, Frederic Eeckman, Monique Berwaer
  • Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivative
    Publication number: 20190142759
    Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: January 7, 2019
    Publication date: May 16, 2019
    Inventors: Domenico Fanara, Frederic Eeckman, Monique Berwaer
  • Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivative
    Patent number: 10172805
    Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: January 8, 2019
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Domenico Fanara, Frédéric Eeckman, Monique Berwaer
  • Formulations
    Patent number: 8946229
    Abstract: The present invention relates to pharmaceutical compositions for oral administration of active compounds.
    Type: Grant
    Filed: August 28, 2008
    Date of Patent: February 3, 2015
    Assignee: UCB, Inc.
    Inventors: Domenico Fanara, Monique Berwaer, Anthony Guichaux, Michel Deleers
  • Pharmaceutical compositions comprising Brivaracetam
    Patent number: 8563036
    Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Grant
    Filed: February 5, 2010
    Date of Patent: October 22, 2013
    Assignee: UCB Pharma, S.A.
    Inventors: Frédéric Eeckman, Domenico Fanara, Monique Berwaer
  • Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate
    Patent number: 8460712
    Abstract: The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation made of granules containing the active ingredient in their inner core.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: June 11, 2013
    Assignee: UCB Pharma, S.A.
    Inventors: Domenico Fanara, Frédéric Eeckman, Monique Berwaer
  • Pharmaceutical compositions comprising brivaracetam
    Patent number: 8435564
    Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: May 7, 2013
    Assignee: UCB Pharma, S.A.
    Inventors: Frederic Eeckman, Monique Berwaer, Domenico Fanara
  • Pharmaceutical Compositions Comprising Brivaracetam
    Publication number: 20120040006
    Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: February 5, 2010
    Publication date: February 16, 2012
    Applicant: UCB PHARMA, S.A.
    Inventors: Frédéric Eeckman, Domenico Fanara, Monique Berwaer
  • FORMULATIONS
    Publication number: 20120010218
    Abstract: The present invention relates to pharmaceutical compositions for oral administration of active compounds.
    Type: Application
    Filed: September 23, 2011
    Publication date: January 12, 2012
    Inventors: Domenico Fanara, Monique Berwaer, Anthony Guichaux, Michel Deleers
  • Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives
    Publication number: 20110281929
    Abstract: The present invention relates to an immediate release formulation of pharmaceutical compounds.
    Type: Application
    Filed: January 27, 2010
    Publication date: November 17, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Serge Cuypers, Monique Berwaer, Domenico Fanara, Valery Barillaro
  • Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives
    Publication number: 20110275693
    Abstract: The present invention relates to an immediate release formulation of pharmaceutical compounds.
    Type: Application
    Filed: January 27, 2010
    Publication date: November 10, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Serge Cuypers, Monique Berwaer, Domenico Fanara, Valery Barillaro, Martine Larbanoix, Frederic Dargelas
  • Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivate
    Publication number: 20110274762
    Abstract: The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation made of granules containing the active ingredient in their inner core.
    Type: Application
    Filed: November 17, 2009
    Publication date: November 10, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Domenico Fanara, Frederic Eeckman, Monique Berwaer
  • Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivative
    Publication number: 20110250282
    Abstract: The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: November 17, 2009
    Publication date: October 13, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Domenico Fanara, Frédéric Eeckman, Monique Berwaer
  • Pharmaceutical Compositions Comprising Brivaracetam
    Publication number: 20110091547
    Abstract: The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: May 28, 2009
    Publication date: April 21, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Frederic Eeckman, Monique Berwaer, Domenico Fanara, Domenico Fanara
  • Novel Pharmaceutical Compositions Comprising Levetiracetam
    Publication number: 20110027359
    Abstract: The present invention relates to a pharmaceutical composition comprising levetiracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: March 10, 2010
    Publication date: February 3, 2011
    Applicant: UCB, S.A.
    Inventors: Caroline Goffin, Monique Berwaer, Michaël Boonen, Michel Deleers, Domenico Fanara
  • Formulations
    Publication number: 20090047344
    Abstract: The present invention relates to pharmaceutical compositions for oral administration of active compounds.
    Type: Application
    Filed: August 28, 2008
    Publication date: February 19, 2009
    Inventors: Domenico Fanara, Monique Berwaer, Anthony Guichaux, Michel Deleers
  • TABLET COMPRISING EFLETIRIZINE AND PSEUDOEPHEDRINE
    Publication number: 20080206331
    Abstract: The present invention concerns a tablet comprising two distinct segments. More particularly the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
    Type: Application
    Filed: June 14, 2007
    Publication date: August 28, 2008
    Applicant: UCB, S.A.
    Inventors: Monique Berwaer, Anthony Guichaux, Serge Cuypers, Michel Deleers, Domenico Fanara
  • NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING LEVETIRACETAM
    Publication number: 20080014264
    Abstract: The present invention relates to a pharmaceutical composition comprising levetiracetam as active ingredient, the invention relates specifically to a prolonged release formulation.
    Type: Application
    Filed: March 2, 2007
    Publication date: January 17, 2008
    Applicant: UCB, S.A.
    Inventors: Caroline Goffin, Monique Berwaer, Michael Boonen, Michel Deleers, Domenico Fanara
  • Tablet comprising cetirizine and pseudoephedrine
    Patent number: 7226614
    Abstract: The present invention concerns a tablet comprising two distinct segments. More particularly, the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
    Type: Grant
    Filed: October 18, 2005
    Date of Patent: June 5, 2007
    Assignee: UCB Farchim SA
    Inventors: Domenico Fanara, Anthony Guichaux, Monique Berwaer, Michel Deleers